Concord Biotech Limited
Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company and manufacturer of fermentation-based APIs across immunosuppressants and oncology.
What Concord files
- Investor Meet42
- Others42
- Important20
- Board Meeting13
- PPTs7
- Dividend/Bonus4
Concord Biotech Secures Abbreviated New Drug Application (ANDA) Approval for Tofacitinib Tablets, 5 mg and 10 mg
Concord Biotech's board updated its Key Managerial Personnel (KMP) list. These KMPs are now authorized to determine material events and make necessary disclosures to stock exchanges. This streamlines internal governance and transparency.
Concord Biotech revised its Key Managerial Personnel (KMPs) list, outlining those responsible for company disclosures to stock exchanges. This streamlines internal communication processes.
Concord Biotech's Limbassi API facility completed its EU-GMP inspection. This validates quality standards and unlocks market expansion into EU and other regulated geographies, boosting global presence and growth.